Skip to content

Weight-control Effect of Rice-based Diet

Weight-control Effect of Rice-based Diet

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000315
Enrollment
800
Registered
2012-01-09
Start date
2012-01-13
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Behavioral : Both groups will be provided low-calory, low-fat and low-sodium diet education and nutrition education materials at 0 week and 12week. Additionally, rice-based diet group will be educate

Sponsors

Inje University Seoul Paik Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? any 3 of 5 constitute diagnosis of metabolic syndrome 1. Elevated waist circumference : =90 cm in men =85 cm in women 2. Elevated triglycerides : =150 mg/dL (1.7 mmol/L) or On drug treatment for elevated triglycerides 3. Reduced HDL-C : <40 mg/dL (1.03 mmol/L) in men <50 mg/dL (1.3 mmol/L) in women or On drug treatment for reduced HDL-C‡ 4. Elevated blood pressure: =130 mm Hg systolic blood pressure or =85 mm Hg diastolic blood pressure or On antihypertensive drug treatment in a patient with a history of hypertension 5. Elevated fasting glucose : =100 mg/dL or On drug treatment for elevated glucose ? Patients who agreed to write about food diary and physical activity Questionnaire ? Patients who agreed to participate volutary in this clinical trial

Exclusion criteria

Exclusion criteria: ? The patients with physical measurements are difficult due to anatomical change, such as surgical resection of part of the body ? The Patients with thyroid fuction disease (TSH is under 0.1 uU/ml, or over 10 uU/ml) ? The Patients with severe cerebrovascular disease(infarct, hemorrage), cardiac disease(angina, myocardiac infarct, heart failure, arrhythmias that require treatment) within recent 6 months. (If that patient's clinical status is stable, they can participate in the clinical trial according to investgator) ? The Patients with severe liver or kidney function abnormality - plasma ALT or AST level is more than 3 times the upper limit of normal - plsma creatinine level is more than 1.5 times the upper limit of normal ? The Patients with mental illness such as depression, Schizophrenia, alcoholism, drug addiction etc. ? Pregnant and lactating women, and women of childbearing age who do not agree with choose an appropriate contraceptive method or are planning to pregnant ? The patient who take the medicine that can affect the state of weight, glucose and lipid level (uptake inhibitors, antidepressant, appetite suppressant, antiobesity-related health functional food / supplements, antipsychotics, contraceptives, steroid, and hormon)within recent 3 months ? The patients who had surgical procedure for reducing weight (bariatric surgery such as gastric bypass and gastric banding) ? The patients who lose weignt over 10 percent within 3 months ? The patients who took part in other clinical trial within 3 months ? The patients who cannot excersise due to severe musculoskeletal disorders ? The patients who stopped smoking within recent 6 months or chage frequently smoking habit ? The patients who have low motivation for attending or will not following the observances of this clinical trial, depend on opinion of representative clinical trials

Design outcomes

Primary

MeasureTime frame
weight ;waist circumference;triglyceride ;HDL-cholesterol;fasting glucose;blood pressure

Secondary

MeasureTime frame
body mass index;hip circumference;fat maas, free fat mass;total-cholesterol;insulin;highly sensitive C-reactive protein(hsCRP);calory of each diet;Nutrients of each diet;LDL-cholesterol

Countries

Korea, Republic of

Contacts

Public ContactYang Hur

Inje University Seoul Paik Hospital

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026